• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatrics . Acceptability and Feasibility of Saliva-delivered PCR Coronavirus 2019 Tests for Young Children

tetano

Editor, Senior Moderator
Pediatrics


. 2023 Jul 1;152(Suppl 1):e2022060352D.
doi: 10.1542/peds.2022-060352D. Acceptability and Feasibility of Saliva-delivered PCR Coronavirus 2019 Tests for Young Children

Rebecca E Lee[SUP] 1 [/SUP], Michael Todd[SUP] 2 [/SUP], Hyunsung Oh[SUP] 3 [/SUP], SeungYong Han[SUP] 2 [/SUP], Michelle Santana[SUP] 1 [/SUP], Jaquelyn Aguilar-Troncoso[SUP] 1 [/SUP], Meg Bruening[SUP] 4 [/SUP], Joanna L Kramer[SUP] 5 [/SUP], Tomás León[SUP] 6 [/SUP], Vel Murugan[SUP] 7 [/SUP], Hector Valdez[SUP] 1 [/SUP], Michelle Villegas-Gold[SUP] 8 [/SUP]



Affiliations
Abstract

Objectives: Access to readily available, reliable, and easy-to-use coronavirus disease 2019 (COVID-19) tests remains critical, despite great vaccination progress. Universal back-to-school testing offered at early care and education ([ECE]; ie, preschool) sites to screen for positive cases may help preschoolers safely return to, and stay in, ECE. We examined the acceptability and feasibility of using a quantitative polymerase chain reaction COVID-19 saliva test for young children (n = 227, 54.0% girls: mean age = 52.3 ± 8.1 months) and their caregivers (n = 70 teachers: mean = 36.6 ± 14.7 years; n = 227 parents: mean = 35.5 ± 9.1 years) to mitigate the spread of COVID-19 and reduce days of school and work missed for households with children who test positive.
Methods: Participants were recruited at ECE sites serving low-income communities as part of the Rapid Acceleration of Diagnostic Testing-Underserved Populations Back to Early Care and Education Safely with Sustainability via Active Garden Education project (NCT05178290).
Results: Surveys in English or Spanish administered at testing events to children and caregivers at ECE sites showed child and adult acceptability and feasibility ratings were generally high. More favorable child and parent ratings were positively associated with child age and whether the child was able to produce a saliva sample. Language preference was not associated with any outcomes.
Conclusions: Saliva sampling for COVID-19 at ECE sites is an acceptable strategy as an additional layer of protection for 4- and 5-year-olds; however, alternate testing strategies may be needed for younger children.


 
Back
Top Bottom